Novo Nordisk Medicare - Search News

US targets Novo Nordisk's Ozempic and Wegovy

Novo's Ozempic, Wegovy picked for US Medicare price negotiations

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.

Hosted on MSN · 1d

Novo Nordisk stock prices drop after Biden lists Ozempic for price negotiations

Stock prices for Novo Nordisk dropped precipitously Friday after a last-minute announcement from the Biden administration that the premier drugs from the Danish pharmaceutical juggernaut have been selected for forced price negotiations for Medicare.

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

2hon MSN

Why Did Novo Nordisk (NVO) Go Down on Friday?

We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...

1don MSN

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

1don MSN

White House says popular weight-loss drug Ozempic subject to Medicare talks

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...

5don MSN

Patient groups call on Trump administration to let Medicare cover obesity drugs

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results